Dr. Zeldin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
30 Eagle Ridge Way
West Orange, NJ 07052Phone+1 347-944-9846- Is this information wrong?
Summary
- Dr. Gillian Zeldin is a transplant hepatologist in West Orange, NJ. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 26 years. She specializes in hepatology & liver transplantation medicine and is experienced in hepatology, transplant hepatology, biliary tract disease, amyloidosis, and hematologic oncology.
Education & Training
- Johns Hopkins UniversityFellowship, Gastroenterology, 1994 - 1998
- UPMC Medical EducationResidency, Internal Medicine, 1991 - 1994
- Rutgers Robert Wood Johnson Medical SchoolClass of 1991
- Trenton State CollegeBA, Biology, 1982 - 1985
Certifications & Licensure
- NJ State Medical License 2005 - 2023
- PA State Medical License 1998 - 2006
Publications & Presentations
PubMed
- 7 citationsAbsence of effect of telbivudine on cardiac repolarization: results of a thorough QT/QTc study in healthy participants.Fred Poordad, Gillian Zeldin, Stuart I. Harris, June Ke, Limin Xu, Douglas L. Mayers, X.-J. Zhou> ;Journal of Clinical Pharmacology. 2009 Dec 1
- 7 citationsWhat is the best immunosuppression in living donor liver transplantationBurckhardt Ringe, Michael J. Moritz, G. Zeldin, Humberto Soriano> ;Transplantation Proceedings. 2005 Jun 1
- 17 citationsSafety and efficacy of living donor liver preservation with HTK solution.Burckhardt Ringe, F Braun, Michael J. Moritz, G. Zeldin, Humberto Soriano, William C. Meyers> ;Transplantation Proceedings. 2005 Jan 1
- Join now to see all
Journal Articles
- What is the best immunosuppression in living donor liver transplantation?Ringe B, Moritz M, Zeldin G, Soriano H., Transplantation Proceedings, 1/1/2005
- Safety and Efficacy of Living Donor Liver Preservation with HTK SolutionRinge B, Braun F, Moritz M, Zeldin G, Soriano, Meyers W., Transplantation Proceedings, 1/1/2005
- Effect of donor hepatitis C on liver graft survivalVelidedeoglu E, Desai NM, Campos L, Olthoff KM, Shaked A, Nunes F, Zeldin G, Stewart C, Blumberg E, Abrams J, Markmann JF, Transplant Proc., 1/1/2001
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- What is the Best Immunosuppression in Live Donor Liver Transplantation?Ringe B, Moritz M, Zeldin Z, Soriano H, American Society of Transplant Surgeons, Miami Beach, Florida, 1/1/2005
- The outcome of livers from HCV positive donors.Velidedeoglu E, Desai N, Campos L, Olthoff K, Shaked A, Forman L, Zeldin GA, Stewart C, Nunes F, Blumberg E, Abrams J, Lucey M., American Society of Transplantation, Chicago, Illinois, 1/1/2001
- Outcome of transplantation of marginal liver grafts in high-need patients: evaluation of physician based organ allocation.Markmann J, Velidedeoglu E, Olthoff K, Shaked A, Zamir G, Stewart C, Zeldin GA, Nunes F, Schultz C, Burke A, Hibbler J, Kovalovich K, Abrams J, Lucey M, American Society of Transplantation, Chicago, Illinois, 1/1/2000
- Join now to see all
Lectures
- Hepatitis C: What You Need to Know, an Update on Pegasys and CopegusSheraton Rittenhouse, Philadelphia, PA - 1/2./2004
- Hepatitis C treatment, Projects in KnowledgePark Hyatt Philadelphia, Philadelphia, PA - 1/9./2004
- Hepatic DysfunctionDrexel University College of Medicine, Surgical Classroom, Philadelphia, PA - 1/22/2004
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: